Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Cash & Current Investments: 2010-2025

Historic Cash & Current Investments for Argan (AGX) over the last 16 years, with Jan 2025 value amounting to $298.4 million.

  • Argan's Cash & Current Investments rose 41.31% to $423.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.3 billion, marking a year-over-year increase of 8.48%. This contributed to the annual value of $298.4 million for FY2025, which is 2.65% down from last year.
  • Per Argan's latest filing, its Cash & Current Investments stood at $298.4 million for FY2025, which was down 2.65% from $306.5 million recorded in FY2024.
  • In the past 5 years, Argan's Cash & Current Investments ranged from a high of $456.7 million in FY2021 and a low of $298.4 million during FY2025.
  • Over the past 3 years, Argan's median Cash & Current Investments value was $306.5 million (recorded in 2024), while the average stood at $310.1 million.
  • In the last 5 years, Argan's Cash & Current Investments surged by 39.30% in 2021 and then declined by 26.12% in 2023.
  • Over the past 5 years, Argan's Cash & Current Investments (Yearly) stood at $456.7 million in 2021, then fell by 3.55% to $440.5 million in 2022, then declined by 26.12% to $325.5 million in 2023, then dropped by 5.82% to $306.5 million in 2024, then decreased by 2.65% to $298.4 million in 2025.